In the United States, the biomedical industry encounters numerous regulatory challenges in conducting nonclinical and ...

On January 16, 2025, the U.S. Food and Drug Administration (“FDA”) published a highly anticipated proposed rule on front-of-package (“FOP”) ...

Despite growing interest in using PCR materials in packaging to reduce virgin plastic use, producers and recyclers report ...

Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and ...

The global drug discovery services market is set for remarkable growth, with its valuation projected to surge from USD 19.7 ...

The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as ...

Lab-developed tests (LDTs) are laboratory tests where blood is drawn and placed in a test tube to help with identification, ...

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

Robert Kennedy Jr. indicated he would consider authorizing the government to seize patents of high-priced medicines to lower ...

Drugmakers raised the prices of more than 800 prescription drugs for blood pressure, cancer, and other conditions by 4% at the beginning of the ...

The University of Chicago is partnering with a health care investment firm that has pledged up to $130 million to help turn ...

Funding Freeze Sets Off New Fight Over Trump’s Vision for His Government President Trump’s order freezing trillions of dollars in federal grants and loans seeks to eliminate all spending on ...